JP2010510260A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010510260A5 JP2010510260A5 JP2009537507A JP2009537507A JP2010510260A5 JP 2010510260 A5 JP2010510260 A5 JP 2010510260A5 JP 2009537507 A JP2009537507 A JP 2009537507A JP 2009537507 A JP2009537507 A JP 2009537507A JP 2010510260 A5 JP2010510260 A5 JP 2010510260A5
- Authority
- JP
- Japan
- Prior art keywords
- skin
- layer
- transdermal therapeutic
- therapeutic system
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000010410 layer Substances 0.000 claims description 34
- 210000003491 Skin Anatomy 0.000 claims description 27
- 239000004480 active ingredient Substances 0.000 claims description 19
- 239000011248 coating agent Substances 0.000 claims description 14
- 238000000576 coating method Methods 0.000 claims description 14
- 230000001225 therapeutic Effects 0.000 claims description 13
- 239000000853 adhesive Substances 0.000 claims description 7
- 230000001070 adhesive Effects 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 6
- 229920002367 Polyisobutene Polymers 0.000 claims description 5
- -1 acrylic ester Chemical class 0.000 claims description 5
- 229920001577 copolymer Polymers 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000011241 protective layer Substances 0.000 claims description 3
- PJMPHNIQZUBGLI-UHFFFAOYSA-N Fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 claims 5
- 229960001391 Alfentanil Drugs 0.000 claims 2
- 229960002428 Fentanyl Drugs 0.000 claims 2
- IDBPHNDTYPBSNI-UHFFFAOYSA-N N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide Chemical group C1CN(CCN2C(N(CC)N=N2)=O)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 IDBPHNDTYPBSNI-UHFFFAOYSA-N 0.000 claims 2
- 229960003394 Remifentanil Drugs 0.000 claims 2
- ZTVQQQVZCWLTDF-UHFFFAOYSA-N Remifentanil Chemical compound C1CN(CCC(=O)OC)CCC1(C(=O)OC)N(C(=O)CC)C1=CC=CC=C1 ZTVQQQVZCWLTDF-UHFFFAOYSA-N 0.000 claims 2
- 229960004739 Sufentanil Drugs 0.000 claims 2
- 230000000202 analgesic Effects 0.000 claims 2
- 230000003364 opioid Effects 0.000 claims 2
- 239000002985 plastic film Substances 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- GGCSSNBKKAUURC-UHFFFAOYSA-N sufentanil Chemical compound C1CN(CCC=2SC=CC=2)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 GGCSSNBKKAUURC-UHFFFAOYSA-N 0.000 claims 2
- JHPBZFOKBAGZBL-UHFFFAOYSA-N (3-hydroxy-2,2,4-trimethylpentyl) 2-methylprop-2-enoate Chemical compound CC(C)C(O)C(C)(C)COC(=O)C(C)=C JHPBZFOKBAGZBL-UHFFFAOYSA-N 0.000 claims 1
- 229940035676 ANALGESICS Drugs 0.000 claims 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 1
- 239000008186 active pharmaceutical agent Substances 0.000 claims 1
- 239000000730 antalgic agent Substances 0.000 claims 1
- 230000003178 anti-diabetic Effects 0.000 claims 1
- 230000000648 anti-parkinson Effects 0.000 claims 1
- 239000000939 antiparkinson agent Substances 0.000 claims 1
- 230000003182 bronchodilatating Effects 0.000 claims 1
- 239000000168 bronchodilator agent Substances 0.000 claims 1
- 238000009792 diffusion process Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 238000003475 lamination Methods 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims 1
- 239000011877 solvent mixture Substances 0.000 claims 1
- 230000000261 vasodilator Effects 0.000 claims 1
- 239000003071 vasodilator agent Substances 0.000 claims 1
- XTXRWKRVRITETP-UHFFFAOYSA-N vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006054733.0 | 2006-11-21 | ||
| DE102006054733A DE102006054733A1 (de) | 2006-11-21 | 2006-11-21 | Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit |
| PCT/EP2007/009707 WO2008061639A1 (fr) | 2006-11-21 | 2007-11-09 | Système thérapeutique transdermique avec un taux d'utilisation de la substance active élevé et une posologie plus précise |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015229478A Division JP6109280B2 (ja) | 2006-11-21 | 2015-11-25 | 活性物質の利用率及び用量精度の高い経皮治療システム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010510260A JP2010510260A (ja) | 2010-04-02 |
| JP2010510260A5 true JP2010510260A5 (fr) | 2013-07-04 |
| JP5881935B2 JP5881935B2 (ja) | 2016-03-09 |
Family
ID=39060261
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009537507A Active JP5881935B2 (ja) | 2006-11-21 | 2007-11-09 | 活性物質の利用率及び用量精度の高い経皮治療システム |
| JP2015229478A Active JP6109280B2 (ja) | 2006-11-21 | 2015-11-25 | 活性物質の利用率及び用量精度の高い経皮治療システム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015229478A Active JP6109280B2 (ja) | 2006-11-21 | 2015-11-25 | 活性物質の利用率及び用量精度の高い経皮治療システム |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US9056026B2 (fr) |
| EP (1) | EP2094213B1 (fr) |
| JP (2) | JP5881935B2 (fr) |
| KR (1) | KR101471216B1 (fr) |
| CN (1) | CN101522146B (fr) |
| AU (1) | AU2007323401C1 (fr) |
| BR (1) | BRPI0719006B8 (fr) |
| CA (1) | CA2662510C (fr) |
| DE (1) | DE102006054733A1 (fr) |
| ES (1) | ES2549692T3 (fr) |
| IL (1) | IL198714A0 (fr) |
| MX (1) | MX2009005343A (fr) |
| NZ (1) | NZ575043A (fr) |
| RU (1) | RU2454994C2 (fr) |
| WO (1) | WO2008061639A1 (fr) |
| ZA (1) | ZA200902579B (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
| DE102006054733A1 (de) * | 2006-11-21 | 2008-05-29 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit |
| DE102011100619A1 (de) | 2010-05-05 | 2012-01-05 | Amw Gmbh | Transdermales therapeutisches System (TTS) mit einem Gehalt an einem Opiod-Analgetikum |
| CA2841785A1 (fr) | 2011-07-06 | 2013-01-10 | The Parkinson's Institute | Compositions et methodes de traitement de symptomes chez des patients atteints de la maladie de parkinson |
| DE102011114411A1 (de) * | 2011-09-26 | 2013-03-28 | Lts Lohmann Therapie-Systeme Ag | Pflaster mit einstellbarer Okklusion |
| TW201431570A (zh) | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片 |
| ES2694662T3 (es) | 2013-07-03 | 2018-12-26 | Lts Lohmann Therapie-Systeme Ag | Sistema terapéutico transdérmico con componente electrónico |
| CA2948219C (fr) | 2014-05-20 | 2023-04-04 | Lts Lohmann Therapie-Systeme Ag | Methode de regulation de liberation d'agent actif dans un systeme d'administration transdermique |
| CA2948220C (fr) | 2014-05-20 | 2023-06-20 | Lts Lohmann Therapie-Systeme Ag | Systeme d'administration transdermique contenant de la rotigotine |
| EP4238580A3 (fr) | 2014-05-20 | 2023-10-25 | LTS Lohmann Therapie-Systeme AG | Systeme d'administration transdermique comprenant un mediateur d'interface |
| JP6940407B2 (ja) * | 2014-12-19 | 2021-09-29 | キンデーバ ドラッグ デリバリー リミティド パートナーシップ | フェンタニルを含む経皮薬物送達デバイス |
| CA2974324A1 (fr) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Procedes et systemes d'administration de medicament |
| JP2018511127A (ja) | 2015-03-12 | 2018-04-19 | クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． | 渇望入力及び支援システム |
| WO2018129304A1 (fr) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Dispositifs et methodes d'administration transdermique de medicament |
| DE102017127433A1 (de) * | 2017-11-21 | 2019-05-23 | Lts Lohmann Therapie-Systeme Ag | TTS auf Basis von klebenden Weichmacher-Polymer-Matrices |
| US11596779B2 (en) | 2018-05-29 | 2023-03-07 | Morningside Venture Investments Limited | Drug delivery methods and systems |
| WO2020095975A1 (fr) * | 2018-11-09 | 2020-05-14 | 株式会社メドレックス | Timbre transdermique contenant du fentanyl comme principe actif |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3315272C2 (de) | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
| US5124157A (en) * | 1989-08-18 | 1992-06-23 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
| US5240711A (en) | 1989-11-29 | 1993-08-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system comprising as active component buprenorphine |
| JPH1036265A (ja) | 1996-07-19 | 1998-02-10 | Nitto Denko Corp | ブプレノルフィン経皮吸収製剤 |
| AU778992B2 (en) | 1998-12-07 | 2004-12-23 | Agi Therapeutics Research Limited | Transdermal patch for delivering volatile liquid drugs |
| DE10012908B4 (de) * | 2000-03-16 | 2005-03-17 | Lts Lohmann Therapie-Systeme Ag | Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung |
| DE10054479A1 (de) * | 2000-11-03 | 2002-05-08 | Henkel Kgaa | Kosmetische Pflaster zur Hautaufhellung |
| US6682757B1 (en) * | 2000-11-16 | 2004-01-27 | Euro-Celtique, S.A. | Titratable dosage transdermal delivery system |
| DE10103860B4 (de) | 2001-01-30 | 2004-12-23 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung |
| DE10110391A1 (de) | 2001-03-03 | 2002-09-26 | Lohmann Therapie Syst Lts | Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff |
| DE10141650C1 (de) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
| DK1455893T3 (da) * | 2001-12-20 | 2007-04-02 | Alza Corp | Elektrotransportindretning med et integralt stöbt reservoirhus |
| JP2003300873A (ja) * | 2002-04-12 | 2003-10-21 | Nitto Denko Corp | 貼付剤およびその製造方法 |
| AR033748A1 (es) | 2002-05-15 | 2004-01-07 | Thalas Group Inc | Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo |
| DK1589955T3 (da) | 2003-02-07 | 2007-03-12 | Lohmann Therapie Syst Lts | Transdermalt terapeutisk system til anvendelse ved varme for at fremme indtrængningen af aktive stoffer og anvendelsen deraf |
| DE102004003224A1 (de) * | 2003-02-07 | 2004-08-26 | Lts Lohmann Therapie-Systeme Ag | Für die Wärmeanwendung zur Beschleunigung der Permeation von Wirkstoffen geeignetes transdermales System und seine Verwendung |
| US8524272B2 (en) * | 2003-08-15 | 2013-09-03 | Mylan Technologies, Inc. | Transdermal patch incorporating active agent migration barrier layer |
| US20050202073A1 (en) * | 2004-03-09 | 2005-09-15 | Mylan Technologies, Inc. | Transdermal systems containing multilayer adhesive matrices to modify drug delivery |
| EP1807033B1 (fr) * | 2004-10-08 | 2016-07-20 | Noven Pharmaceuticals, Inc. | Dispositif d'administration transdermique de medicaments avec couche support occlusive |
| DE102005011517A1 (de) * | 2005-03-10 | 2006-09-21 | Grünenthal GmbH | Transdermales therapeutisches System zur Verabreichung von Analgetika |
| DE102006026060B4 (de) | 2006-01-12 | 2013-01-31 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System enthaltend als Wirkstoff Nikotin und Verfahren zur Herstellung solcher Systeme |
| US20070298961A1 (en) | 2006-06-22 | 2007-12-27 | Rice Gordon L | Method of producing electrodes |
| DE102006054733A1 (de) * | 2006-11-21 | 2008-05-29 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit |
-
2006
- 2006-11-21 DE DE102006054733A patent/DE102006054733A1/de not_active Withdrawn
-
2007
- 2007-11-09 JP JP2009537507A patent/JP5881935B2/ja active Active
- 2007-11-09 AU AU2007323401A patent/AU2007323401C1/en not_active Ceased
- 2007-11-09 KR KR1020097010299A patent/KR101471216B1/ko active IP Right Grant
- 2007-11-09 RU RU2009123370/15A patent/RU2454994C2/ru not_active IP Right Cessation
- 2007-11-09 US US12/515,630 patent/US9056026B2/en active Active
- 2007-11-09 EP EP07819712.6A patent/EP2094213B1/fr active Active
- 2007-11-09 CA CA2662510A patent/CA2662510C/fr active Active
- 2007-11-09 NZ NZ575043A patent/NZ575043A/en not_active IP Right Cessation
- 2007-11-09 BR BRPI0719006A patent/BRPI0719006B8/pt active IP Right Grant
- 2007-11-09 WO PCT/EP2007/009707 patent/WO2008061639A1/fr active Application Filing
- 2007-11-09 MX MX2009005343A patent/MX2009005343A/es active IP Right Grant
- 2007-11-09 ES ES07819712.6T patent/ES2549692T3/es active Active
- 2007-11-09 CN CN2007800372464A patent/CN101522146B/zh active Active
-
2009
- 2009-04-15 ZA ZA2009/02579A patent/ZA200902579B/en unknown
- 2009-05-12 IL IL198714A patent/IL198714A0/en unknown
-
2015
- 2015-05-11 US US14/709,126 patent/US9421174B2/en active Active
- 2015-11-25 JP JP2015229478A patent/JP6109280B2/ja active Active
-
2016
- 2016-07-21 US US15/216,446 patent/US9717698B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010510260A5 (fr) | ||
| JP6109280B2 (ja) | 活性物質の利用率及び用量精度の高い経皮治療システム | |
| JP2016502989A5 (fr) | ||
| KR101685736B1 (ko) | 중합체 필름 내 약제의 결정화를 방지하는 방법 | |
| CZ20032813A3 (cs) | Transdermální náplast pro podání fentanylu | |
| JP2015500329A5 (fr) | ||
| JP2016504368A5 (fr) | ||
| JP2013079281A5 (fr) | ||
| JP2011527697A5 (fr) | ||
| US20140105979A1 (en) | Compositions and methods for the transdermal delivery of methylphenidate | |
| KR20160108831A (ko) | 남용 및 오용 저지 경피 시스템 | |
| TWI344374B (en) | Therapeutic composition structure with multilayer for transmucosal admistration | |
| JP5954919B2 (ja) | 揮発性および／または熱不安定性物質用の経皮吸収治療システム | |
| JP2004529890A (ja) | 活性成分としてのニコチンを有する可撓性の著しい皮膚透過性治療系 | |
| JP7072520B2 (ja) | 二重ディスク経皮システム | |
| JP6832287B2 (ja) | ２層の接着層を含むオーバーテープを用いる経皮治療システム | |
| KR101583680B1 (ko) | 펜타닐의 1일-1회 교체 경피 투여 | |
| JP2011500604A5 (fr) | ||
| CA2513402A1 (fr) | Systeme therapeutique transdermique apte a une application thermique visant a augmenter la permeation de substances actives, et utilisation associee | |
| ZA200505629B (en) | Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances and the use thereof | |
| JP2011510936A5 (fr) | ||
| JP2009534343A (ja) | スフェンタニル及びその類似体を含んでなる経皮送達システム | |
| JPH059115A (ja) | ニトログリセリンを含有する感圧性粘着テープまた はシートの製造方法 | |
| JPWO2021078761A5 (fr) | ||
| JPS61251618A (ja) | 外用医薬部材 |